Ifedi Anikpo (@Ifedi_A) profile picture

MBBS, MPH

Miami, FL
Joined October 2018
Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)Photo by Ifedi Anikpo (@Ifedi_A)
Thank you for the feature and for capturing such an exciting moment as I celebrate the completion of my PhD program @univmiami. 👋
Congratulations class of 2025, 🙌 did it! 🎓
1
1
2
39
New Publication!!! One of my research papers, just published with @SpringerNature in the Journal of Racial and Ethnic Health Disparities, examines how length of time in the US is (or is not?) related to cardiometabolic health among Black immigrants: link.springer.com/article/10…
1
41
Many thanks to my co-authors!
56
Intrigued by the idea of using Coronary Artery Calcium scores for "de-risking" of patients who would have been in the statin-eligible category. Do we need more evidence?... I think so! #AHA2023
1
107
Attending #AHA2023. "Understanding Cardiovascular Risk: From Assessment to Implementation" has been the most interesting session for me so far. Thought provoking questions about how we approach CVD risk estimation. Slides by Prof. Ian Graham.
1
121
Thank you @AHAMeetings. And thanks to everyone who shared comments/questions. Looking forward to enjoying the rest of #EPILifestyle23.
2
1
4
1,786
Next up at #Epilifestyle23 we have the Health Disparities and Social Determinants of Health session with this excellent panel. @DrLaPrincess @TSNolanPhD @UREssien @whaleMPH @Ifedi_A @waynerlawrence @American_Heart @JAHA_AHA
1
14
3
50
5,567
Thank you. I was glad to present this study @AHAMeetings #EPILifestyle23
Replying to @fmetlock
Great presentation by @Ifedi_A on “Length of Time in the United States and Cardiometabolic Outcomes Among Foreign and US-Born Black Adults”
1
1
128
Glad to be attending the AHA #EPILifestyle23 in Boston. Presenting my research at the Health Disparities and Social Determinants of Health Session. I'll be speaking about how length of time lived in the US is related to cardiometabolic risk among Black immigrants. #epitwitter
2
144
Was pleased to collaborate with a great team on this study highlighting HIV mortality trends among older adults. #AgingHIVPopulation #EpiTwitter authors.elsevier.com/c/1gXDg…
2
1
262
New research highlighting risk of #cardiotoxicity after #breastcancer treatment.
New @JPS_Research: High risk of cardiotoxicity for socioeconomically marginalized women with breast #cancer treated with anthracyclines or trastuzumab. High prevalence of #CVD risk factors at baseline. link.springer.com/article/10… @oncoalert @breastcaupdates #BCSM #cardiooncology
On today's episode of Meeting Great People in Epi, I had the pleasure of chatting with @sandrogalea at #SER2022.
1
And that's how you know #SER2022 is in full swing. #EpiHumor
2
*EARLY VIEW* *OPEN ACCESS* The data-collection on adverse effects of anti-HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV onlinelibrary.wiley.com/doi/…
Glad to share this important work I conducted with my colleagues at @JPS_Health. We evaluated the performance of a prominent model for predicting #CVD risk among people living with #HIV. Published in @HIV_Medicine. #epitwitter #medtwitter #clinicalepidemiology
*EARLY VIEW* *OPEN ACCESS* The data-collection on adverse effects of anti-HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV onlinelibrary.wiley.com/doi/…
How well does a cardiovascular disease risk prediction model for people living with HIV work in a diverse safety-net population?... Hope you check out our poster (P293) at #SER2021 to find out. Brought to you by #JPSCEHDR. #HIV #CVD
1
1
What exactly are we measuring?... This commentary on #PatientNavigation might interest you. #epitwitter #substanceuse #JPSCEHDR
This Post is from an account that no longer exists. Learn more
1
1